Skip to content
Peptideworth

Provider review

EverPrime Review: Peptide Evidence, Optional Membership and Care

EverPrime clearly distinguishes compounded GLP-1 treatment from the branded drugs studied in trials. Its sermorelin sleep claims need more caution. Before choosing a plan, separate the medication rate from visit fees and an optional prepaid membership.

By Grant Delaney, Research EditorUpdated

Partner link — we may earn a commission. How we’re paid

Visit EverPrime

Of EverPrime’s 2 dated product claims documented below, 1 is consistent with the cited evidence. Comparable upfront pricing is not established here. A matching claim does not mean the compounded product was tested or FDA-approved.

EverPrime makes a useful distinction between branded GLP-1 trial results and its compounded medicines. The selected sermorelin sleep claim is less well supported. Pharmacy names are published, but the actual dispensing partner, visit charges and prepaid commitment need clarification before buying.

Worth trusting if

  • You want provider-led care and will confirm the prescribed formulation and filling pharmacy.
  • You value a provider that acknowledges its compounded medicines were not the products studied in branded weight-loss trials.
  • You can compare member and nonmember totals, including visits, before choosing optional membership.

Be skeptical if

  • You are expecting a demonstrated sleep or recovery benefit from the sermorelin program.
  • You need a simple verified all-in price before discussing the plan with the service.
  • You want treatment to be refundable after pharmacy preparation has begun.

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

Reviewed

Compounded

Evidence

Phase 3 trials

Pharmacy

Named

FDA letter

None found

Provenance

Products reviewed at EverPrime

These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.

Compounded (503A)2 products

Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

  • GLP-1 Semaglutide — The one-month selector advertises a $249 standard medication rate or $150 member rate. Core membership is an optional additional $99 per month, prepaid under the published terms. Visit fees and the total upfront commitment still need confirmation. Four-week delivery does not establish the billing interval.
  • Sermorelin — The headline displays $129 member and $149 standard pricing. The price selector does not clearly identify the term attached to every amount, so no verified one-month total is assigned here. Membership is additional and optional; ask for the exact term, visits, renewal amount and upfront charge.

Evidence

Has the molecule been tested for what it is sold for?

Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.

Semaglutide · compounded
Phase 3 trials
Sermorelin · compounded
No trial for this use

1

Products with human evidence

For the advertised use, out of 2 products reviewed here. The evidence concerns the molecule, not EverPrime's service.

1

Registry records cited

Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.

The comparison

What they claim, against what the trials show

Each claim below is quoted word for word from EverPrime’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.

GLP-1 SemaglutideSemaglutide · Compounded (503A)Claim matches the trials
“Semaglutide mimics GLP-1, a naturally occurring hormone involved in appetite and blood sugar regulation.”

Read on the EverPrime site, October 2026

Phase 3 trials

What the trials show for Semaglutide

  • NCT03548935 STEP 1 — Phase 3, completed, n=1,961. Branded semaglutide with lifestyle intervention over 68 weeks; not a trial of EverPrime compounded treatment or its care service.

The appetite-regulation explanation is consistent with semaglutide evidence. It does not establish that this compounded formulation delivers the same outcomes as the approved product; EverPrime acknowledges that its compounded medicines have not been separately studied.8

SermorelinSermorelin · Compounded (503A)Claim reaches past the trials
“Support for Restorative Sleep […] Sermorelin may help support the hormonal pathways involved in maintaining lean body mass and physical strength.”

Read on the EverPrime site, October 2026

No trial for this use

What the trials show for Sermorelin

On October 28, 2026, comparison of the public EverPrime sermorelin page with the PubMed-indexed Khorram 1997 GHRH-analog study did not identify controlled evidence validating restorative sleep or recovery from EverPrime's specific product. This is a limited comparison, not an exhaustive literature search: adult human research exists, and the cited study found sleep quality unchanged.

The wording is qualified, but the suggested sleep benefit still exceeds what this study establishes. A small study of a related GHRH analog found lean-mass changes in men and no improvement in sleep; it does not validate EverPrime's compounded formulation, strength benefit or recovery claims.10

Dispensing chain

Who actually fills your prescription

Pharmacy named
  • Rite-Away Pharmacy
  • Vios Compounding Pharmacy
  • TruMedsRx
  • Honeybee Health
  • Wells Pharmacy
Read the full account

The terms name Rite-Away, Vios and TruMedsRx in the service description, with other licensed pharmacies possible. A separate contact list also names Honeybee Health and Wells. These disclosures do not identify the pharmacy for a particular prescription; ask which pharmacy will dispense the selected treatment.

Read on the EverPrime site, October 2026.

Quality

Third-party testing, and what is published

Yes

Describes a testing regime

A described program, not a document.

—

Certificate of analysis readable

A readable lot report was not verified here

Read the full testing account

The selected product pages describe licensed 503A preparation and third-party testing for purity and potency. The reviewed material did not provide a batch-specific certificate we could inspect; those statements do not independently establish potency, sterility or the contents of a particular prescription.

Read on the EverPrime site, October 2026.

Licensing

Licensed to dispense, and where

Coverage

Availability varies by state and treatment; no complete current state list was verified.

Read the full licensing claim

The FAQ and product notices say treatment depends on state and provider evaluation. The terms identify Enhance Wellness, PC, EnhanceMD CA, PC and iThriveMD, PC as clinical groups; these published names are not independent verification of every clinician's license.

Read on the EverPrime site, October 2026.

Regulatory

The FDA warning letter

No FDA warning letter found

None of the 113 warning letters FDA sent to telehealth companies in its September 2025, February 2026 and June 2026 enforcement waves names EverPrime (Enhance MD LLC). Checked in October 2026; that covers those letters, not every action FDA has ever taken.

Assessment

What holds up, and what does not

What holds up
  • The GLP-1 pages distinguish branded trial results from compounded treatment.
  • The terms identify clinical groups and several pharmacy partners.
  • Nonmembers can obtain care; membership is explicitly optional.
What does not
  • The selected sermorelin sleep claim is not established by the cited human study.
  • Membership and visit inclusions differ between the comparison table and FAQ.
  • The membership billing example is contradictory, and a medication rate is not a verified all-in charge.
Show 1 more
  • No complete state list or inspectable batch certificate was verified.

Verdict

The bottom line

Ask for a written quote covering medication, visits, labs, membership and renewal dates. For sermorelin, ask what evidence supports the specific benefit you want and how the clinician will assess whether treatment is helping.

Visit EverPrime

Opens EverPrime's website. A link is not a recommendation to take anything.

What EverPrime offers

EverPrime provides access to GLP-1 weight-management treatment alongside longevity and other therapies. This review assesses selected semaglutide and sermorelin claims, with a separate look at the care and payment terms. It does not grade every product in the catalog or establish that the service outperforms another provider. Treatment requires a clinician's evaluation; a prescription is not guaranteed. 1 4 7

EverPrime's terms identify Enhance MD LLC and expressly include the EverPrime brand. Readers researching the earlier service can also consult our Enhance MD review. That connection does not make an old price, billing interval or state list a current EverPrime fact. The terms distinguish the platform from its clinical groups and dispensing pharmacies. 5

Full analysis — 6 more sectionsWhere the GLP-1 evidence fits · Sermorelin needs a different evidence discussion · The prescription's pharmacy still matters · Membership is optional, and medication is additional · Cancellation and delivery are separate decisions · What to settle before choosing a plan

Where the GLP-1 evidence fits

Semaglutide has substantial clinical weight-loss evidence. STEP 1 studied branded semaglutide with lifestyle intervention in 1,961 adults over 68 weeks. That supports the molecule's role in weight management, not automatic equivalence of a compounded prescription or proof of EverPrime's service results. 8

EverPrime handles an important distinction fairly. Its product pages cite the 72-week SURMOUNT-5 comparison and identify the results as coming from branded drugs at maximum tolerated doses. The trial found average weight changes of 20.2% with tirzepatide and 13.7% with semaglutide in adults with obesity without type 2 diabetes. EverPrime also states that its compounded medicines have not been separately studied and results may differ. Those qualifications should stay attached to the numbers; neither figure is a personal forecast. 1 2 9

Sermorelin needs a different evidence discussion

The sermorelin page connects treatment with sleep, recovery, strength and body composition. Its wording includes caveats and references hormonal pathways, but a biological explanation does not demonstrate that a prescribed program will improve sleep or physical performance. 7

Relevant adult human research exists. Khorram and colleagues studied 19 adults aged 55 to 71 using a related GHRH analog after a placebo period. Some endocrine measures changed, and lean body mass increased in men, but sleep quality was unchanged in both sexes. This small study is not validation of EverPrime's specific preparation, dosing schedule or broader recovery and healthy-aging benefits. It is also a reason to avoid claiming that sermorelin-related therapies have never been studied in adults. 10

The prescription's pharmacy still matters

The terms name Rite-Away Pharmacy, Vios Compounding Pharmacy and TruMedsRx in the fulfillment description. The contact section adds Honeybee Health and Wells Pharmacy. Different lists within the same document are a reason to ask which pharmacy will fill the actual order. They do not prove that an unidentified pharmacy is supplying the treatment. 5

The selected product pages describe licensed 503A compounding and third-party purity and potency testing. Those are provider disclosures, not an independent inspection of a facility or a patient batch. Ask for the filling pharmacy, prescribed ingredients, storage instructions and relevant batch-testing information. Compounded medicines are not FDA-approved. Availability also varies by treatment and state, rather than a verified blanket promise of nationwide access. 1 4 7

Membership is optional, and medication is additional

Core membership is advertised at $99 a month and Peak at $199. The membership FAQ says care is available without membership and medication is priced separately. The comparison table lists nonmember treatment visits at $99 a visit; it also lists Core visit charges that conflict with the FAQ's included-visit wording. Confirm the applicable visit and lab fees instead of assuming either plan includes every service. 3

The GLP-1 selectors show one-month standard medication rates of $249 for semaglutide and $329 for tirzepatide, with separate member rates and lower advertised rates on longer packages. These are medication figures, not verified totals for all care. The sermorelin selector is less clear about the term attached to each displayed amount, so this review does not assign it a one-month total. 1 2 7

Membership is described as prepaid. Its billing example says a three-month medication plan brings a twelve-month membership charge, which conflicts with the preceding explanation tying membership to treatment length. Ask for the exact upfront charge and term before agreeing. The GLP-1 pages describe delivery every four weeks, while the terms leave full payment details to checkout. Delivery frequency does not establish the billing cycle or the number of charges in a year. 1 2 3 5

Cancellation and delivery are separate decisions

The membership FAQ says canceling stops future membership renewals, while payments already made are nonrefundable and benefits continue through the prepaid term. Future medication orders may use nonmember pricing after that term. The shipping policy separately says an order cannot be canceled or refunded once pharmacy preparation begins, and it asks for at least 24 hours' notice before the next billing date to skip a shipment. A provider decision that treatment is unsuitable qualifies for a full refund under that policy. Confirm which terms apply to the particular charge. 3 6

Two-day priority shipping starts after an order ships. Provider review, required visits or labs and pharmacy preparation happen first, and the policy does not guarantee an arrival date. Damaged, incorrect or incomplete deliveries must be reported within 48 hours; replacement depends on pharmacy and provider approval. These details matter more than interpreting two-day shipping as treatment arriving two days after purchase. 6

What to settle before choosing a plan

Get the prescribed formulation, actual dispensing pharmacy, state eligibility and complete payment schedule in writing. A useful conversation about a longevity treatment should also identify the intended benefit, evidence relevant to that benefit and how follow-up will assess it. Access to a clinician and a discounted medication rate are service features; they do not establish the clinical value of every treatment offered. 3 4 7

Questions

Frequently asked questions

Is EverPrime membership required?

No. Its membership FAQ says treatment is available without membership. Core is advertised at $99 a month and Peak at $199, with medication additional. Visit inclusions and prepaid terms need confirmation because parts of the public comparison and FAQ differ.

Does EverPrime sell the same semaglutide used in the weight-loss trials?

The reviewed product page describes a compounded preparation. The branded semaglutide trial results do not automatically transfer to that formulation, and EverPrime explicitly acknowledges that its compounded medicines have not been separately studied.

Does the sermorelin research prove a sleep benefit?

No. The small GHRH-analog study discussed here included older adults and found sleep quality unchanged. That does not validate EverPrime's particular compounded program for sleep or recovery.

Does delivery every four weeks mean billing every four weeks?

No. Delivery and billing are different schedules. The public terms leave full payment details to checkout; confirm the initial payment, renewal amount, dates and prepaid commitment before choosing a plan.

Compare

Others selling what EverPrime sells

Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.

Ranked

The lists EverPrime is on

Method

How we checked this

Non-product facts last checked October 2026. Read the editorial policy for the rules this page is held to.

Read our methodology

Claims read first-party

Every quoted claim was read off EverPrime's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.

Trials read from the registry

Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.

Absence claims bounded

Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.

Letters matched on full name

FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.

Sources

References

Show all 10 sources
  1. EverPrime (2026). GLP-1 Semaglutide. Public product page; checked October 28, 2026. the EverPrime site
  2. EverPrime (2026). GLP-1 + GIP Tirzepatide. Public product page; checked October 28, 2026. the EverPrime site
  3. EverPrime (2026). Membership. Public membership comparison and FAQ; checked October 28, 2026. the EverPrime site
  4. EverPrime (2026). FAQs. Public care and availability disclosures; checked October 28, 2026. the EverPrime site
  5. EverPrime (2026). Terms of Service. Public terms; checked October 28, 2026. the EverPrime site
  6. EverPrime (2026). Shipping & Returns. Public shipping and cancellation policy; checked October 28, 2026. the EverPrime site
  7. EverPrime (2026). Sermorelin. Public product page; checked October 28, 2026. the EverPrime site
  8. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine 384:989–1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  9. Aronne LJ, Horn DB, le Roux CW, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/40353578/
  10. Khorram O, Laughlin GA, Yen SS (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Journal of Clinical Endocrinology and Metabolism 82(5):1472–1479. https://pubmed.ncbi.nlm.nih.gov/9141536/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.